CONGENITAL ADRENAL HYPERPLASIA
Clinical trials for CONGENITAL ADRENAL HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL ADRENAL HYPERPLASIA trials appear
Sign up with your email to follow new studies for CONGENITAL ADRENAL HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy could ease daily steroid dependence for rare hormone disorder
Disease control OngoingThis study tests a new gene therapy for adults with classic congenital adrenal hyperplasia (CAH), a genetic condition that disrupts hormone production and requires lifelong steroid medication. The treatment uses a harmless virus to deliver a working copy of the faulty gene, aimin…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE1, PHASE2 • Sponsor: Adrenas Therapeutics Inc • Aim: Disease control
Last updated May 26, 2026 07:21 UTC
-
New drug could slash steroid use in rare hormone disorder
Disease control OngoingThis study tests a new medicine called crinecerfont for adults with classic congenital adrenal hyperplasia (CAH), a genetic condition that disrupts hormone production. The goal is to see if the drug can safely reduce the high doses of steroids patients need to take daily. About 1…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE3 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Study on virtual Self-Care training for teens with rare hormone disorder pulled before start
Knowledge-focused TerminatedThis study aimed to see if a virtual education program could help teenagers and young adults with congenital adrenal hyperplasia (CAH) learn to manage their own health care as they move from pediatric to adult doctors. It planned to enroll 16- to 22-year-olds already in a related…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA
Phase: NA • Sponsor: National Institutes of Health Clinical Center (CC) • Aim: Knowledge-focused
Last updated May 05, 2026 11:53 UTC